Non-adherent cell-specific expression of DOCK2, a member of the human CDM-family proteins  by Nishihara, Hiroshi et al.
Non-adherent cell-speci¢c expression of DOCK2, a member of the
human CDM-family proteins
Hiroshi Nishihara a;b, Shin Kobayashi a, Yuko Hashimoto c, Fumiyo Ohba a,
Naoki Mochizuki a, Takeshi Kurata c, Kazuo Nagashima b, Michiyuki Matsuda a;*
a Department of Pathology, Research Institute, International Medical Center of Japan, 1-21-1 Toyama, Shinjuku-ku, Tokyo, 162-8655,
Japan
b Department of Pathology, Hokkaido University School of Medicine, Sapporo, 060-8638, Japan
c Department of Pathology, National Institute of Infectious Diseases, Toyama, Shinjuku-ku, Tokyo, 162-8640, Japan
Received 20 May 1999; received in revised form 23 September 1999; accepted 23 September 1999
Abstract
Human DOCK180, which was originally identified as a major protein bound to the Crk oncogene product, is an archetype
of the CDM family of proteins, including Ced-5 of Caenorhabditis elegans and Mbc of Drosophila melanogaster. After
DOCK180, at least three putative human proteins that manifest high amino acid sequence similarity to DOCK180 have been
registered in the GenBank/EMBL database. We have designated one of them, KIAA0209, as DOCK2 and characterize here.
DOCK2 mRNA was expressed mostly in peripheral blood cells, followed by slight expression in the spleen and thymus,
whereas DOCK180 was expressed in all tissues tested except in peripheral blood cells. Immunostaining of human cadaver
tissues revealed that the expression of DOCK2 was limited to the lymphocytes and macrophages of various organs. DOCK2
bound to and activated Rac1, as did DOCK180; however, DOCK2 did not bind to CrkII, which transduces signals at focal
adhesions. Thus, DOCK180 and DOCK2 are regulators of Rac and function in adherent and non-adherent cells,
respectively. ß 1999 Elsevier Science B.V. All rights reserved.
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1. Introduction
CrkII belongs to the adaptor proteins consisting
mostly of the SH2 and SH3 domains [1]. As a com-
plex with its major SH2-binding protein, p130Cas,
CrkII seems to function at focal adhesions [2]. The
CrkII-p130Cas complex regulates the cell migration
[3] and activation of c-jun N-terminal kinase/stress-
activated protein kinase (JNK) [4^6]. DOCK180,
which was isolated as one of the two major proteins
bound to the SH3 domain of an adapter protein,
CrkII [7], transduces signals from the CrkII-p130Cas
complex to both the cytoskeleton and JNK pathway
by means of activation of a low molecular weight G
protein, Rac [8,9]. Both the DOCK180-dependent
activation of JNK and DOCK180-induced cell
spreading were inhibited by a dominant-negative
Rac mutant [8].
Homologs of DOCK180 have been identi¢ed and
characterized in Drosophila melanogaster and Caeno-
rhabditis elegans. Taking the acronyms of Ced-5 of
C. elegans, DOCK180, and Mbc of D. melanogaster,
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these proteins are designated as the CDM-family
proteins [10]. Mbc is necessary for myoblast fusion
and for the migration of epithelial cells, both of
which require reorganization of the cytoskeleton
[11]. Recently, a genetic link between Mbc and Rac
has been demonstrated, suggesting that Mbc may
regulate the cytoskeleton through the activation of
Rac [9]. Loss of function of Ced-5 results in the
defect of engul¢ng dead cells and migration of distal
tip cells of the nematode [10]. Thus, Ced-5 is also
involved in the regulation of the cytoskeleton.
cDNA sequences of three human putative pro-
teins, which share high sequence homology with
DOCK180, have been deposited to the GenBank/
EMBL databases. They are KIAA0209, isolated
from the myeloblast cell line KG-1, KIAA0299
from brain, and GS034D21 from lymphoblastic cells.
This ¢nding strongly suggests that the human CDM-
family proteins consist of at least four proteins; how-
ever, the role of the multiple proteins in this family is
totally unknown. In this report, we characterize the
KIAA0209 protein, which we renamed DOCK2 at
the concession of the original depositor of the
cDNA sequence [12].
2. Materials and methods
2.1. Sequence analysis
The cDNA sequences were aligned by using Clus-
tal W [13]. The nucleotide sequences for KIAA0209,
KIAA0299, and GS034D21 can be accessed through
the GenBank database under GenBank Accession
Numbers D86964, AB002297, and AC003077, re-
spectively.
2.2. Plasmids
cDNA of KIAA0209 is a generous gift from Dr.
Nomura at the Kazusa DNA Institute [12]. An XhoI
restriction site was introduced before the ¢rst initia-
tion codon by PCR-mediated mutagenesis. Then the
full-length cDNA was subcloned into the pCXN2
expression vector [14], with a Flag-tag at its amino-
terminus, to generate pCXN2-Flag-DOCK2. Simi-
larly, deletion mutants were constructed by subclon-
ing of restriction fragments of DOCK2 into pCXN2.
pCXN2-Flag-DOCK2-vN encodes amino acids from
939 to the carboxyl-terminus. pCXN2-Flag-DOCK2-
vCS and pCXN2-Flag-DOCK2-vCL encode
DOCK2 from the amino-terminus to amino acids
515 and 1323, respectively. Expression plasmids for
CrkII, pCAGGS-CrkII, and DOCK180, pCAGGS-
DOCK180 and pCXN2-Flag-DOCK180, have been
reported previously [7,15]. Full-length cDNA of Vav
was also subcloned into the pCXN2-Flag vector [16].
pEBG is an expression vector for glutathione S-
transferase (GST) [17]. cDNAs of Rac1 and Rac2
were obtained from Dr. J.S. Gutkind and Y. Takai,
respectively. Both Rac1 and Rac2 cDNAs were
subcloned into pEBG to generate pEBG-Rac1 and
pEBG-Rac2, respectively.
2.3. Antibodies
cDNA corresponding to the carboxyl-terminal re-
gion of DOCK2 (amino acids 1644 to 1830) was
ampli¢ed by PCR and subcloned into pGEX4T
(Pharmacia) to produce a GST-tagged recombinant
protein. The GST-tagged DOCK2 carboxyl-terminal
region was puri¢ed by glutathione Sepharose and
inoculated into rabbits as described previously [15].
Rabbit polyclonal sera were ¢rst passed through a
GST-loaded column and then puri¢ed on the GST-
DOCK2 a⁄nity column as described [18]. Anti-
DOCK180 antibody and anti-Crk 3A8 monoclonal
antibody have been described previously [7,19]. Anti-
£ag M5 monoclonal antibody and anti-Crk mono-
clonal antibody were purchased from Eastman Ko-
dak Co. and Transduction Lab. (Lexington, KY,
USA) respectively.
2.4. Cells
293T human kidney cells and NRK normal rat
kidney cells were maintained in DMEM containing
10% fetal bovine serum. Jurkat human T cells, Ra-
mos human B cells, and THP-1 human monocyte-
derived cells were cultured in RPMI 1640 containing
10% fetal bovine serum.
2.5. Histochemical staining
Formalin-¢xed, para⁄n-embedded tissues from a
human cadaver were used for analysis. Endogenous
BBAMCR 14557 28-10-99 Cyaan Magenta Geel Zwart
H. Nishihara et al. / Biochimica et Biophysica Acta 1452 (1999) 179^187180
peroxidase activity was blocked by preincubation
with 1% hydrogen peroxide in phosphate-bu¡ered
saline, followed by pretreatment in a microwave
oven twice for 5 min. Sections were preincubated
with 1% bovine serum albumin and incubated with
the anti-DOCK2 a⁄nity-puri¢ed antibody for 1 h at
37‡C, followed by detection of the antibody by a
peroxidase-conjugated streptavidin-DAB readout
system (DAKO Japan Co., Kyoto, Japan). Finally,
the nucleus was counter-stained with Giemsa solu-
tion (Wako Chemicals, Tokyo, Japan).
2.6. Binding to CrkII
293T cells were co-transfected with pCXN2-CrkII
and pCXN2-Flag-DOCK180 or pCXN2-Flag-
DOCK2. Forty-eight h after transfection, cells were
lysed in lysis bu¡er (10 mM Tris-hydrochloride, pH
7.5, 5 mM EDTA, 150 mM NaCl, 1% Triton X-100,
500 WM Na3VO4, 10 mM NaF, 5 Wg/ml aprotinin,
1 mM phenylmethylsulfonyl £uoride). CrkII was im-
munoprecipitated with rabbit antiserum and protein
A-Sepharose [15]. Proteins bound to the beads were
separated by SDS-PAGE and analyzed by immuno-
blotting by the use of anti-Flag monoclonal antibody
or anti-Crk monoclonal antibody, followed by detec-
tion with peroxidase-labeled anti-mouse immunoglo-
bulin and an ECL chemiluminescence system (Amer-
sham).
2.7. Binding to Rac1 or Rac2
Binding of DOCK180 and DOCK2 to GST-Rac1
and GST-Rac2 was analyzed as described previously
[8]. Brie£y, 293T cells were transfected with pEBG-
Rac1 or pEBG-Rac2 and pCXN2-Flag-DOCK180
or pCXN2-Flag-DOCK2. After 48 h, cleared cell ly-
sates were incubated with glutathione Sepharose for
30 min at 4‡C. Proteins collected on glutathione
Sepharose were separated by SDS-PAGE, trans-
ferred to a polyvinylidene di£uoride membrane, and
probed with anti-Flag monoclonal antibody.
2.8. Activation of Rac1 by DOCK2
Analysis of guanine nucleotides bound to Rac1
was described previously [8]. Brie£y, 293T cells
were transfected with pEBG-Rac1 and pCXN2-de-
rived expression vectors. After 3 h of labeling with
32Pi, GST-Rac1 was collected on glutathione Sephar-
ose. The labeled guanine nucleotides on the beads
were analyzed by polyethyleneimine thin-layer chro-
matography.
3. Results
3.1. Identi¢cation of novel human CDM-family
proteins
A database search for the CDM-family proteins by
the use of the DOCK180 amino acid sequence as a
probe has revealed three amino acid sequences in
man, DOCK2, KIAA0299, and GS034D21. We
found that DocA of Dictostylium, also shared high
sequence homology with DOCK180. DOCK180,
DOCK2, Ced-5, and Mbc contain an SH3 domain
at the amino-terminus. The amino acid sequences of
KIAA0299, GS034D21, and DocA did not contain
the amino-terminal region including SH3 (Fig. 1a).
Further study is needed for determining whether
these proteins truly conform only to the C-terminal
region of the CDM family. Shown in Fig. 1b is the
alignment of the amino acid sequences of the over-
lapping regions. The carboxyl-terminal regions of
these proteins are extremely divergent. As a result,
the Crk-binding sites of DOCK180 are not found in
the other three human proteins. The phylogenetic
tree shows that DOCK2 is the closest homolog to
DOCK180 (Fig. 1c). KIAA0299 and GS034D21 ap-
pear to form another subfamily.
In this study, we concentrated on the characteriza-
tion of DOCK2. The cDNA sequence of DOCK2
contained a 5490 bp open reading frame that encodes
1830 amino acids with a calculated molecular mass
of 212 kDa. The amino acid sequence of DOCK2
showed 62.3% identity with DOCK180 when the car-
boxyl-terminal variable regions were omitted.
3.2. Distribution of DOCK2
The expression and distribution of DOCK2
mRNA were examined by Northern blotting analysis
(Fig. 2a). A 7.4 kb transcript was expressed most
abundantly in peripheral blood leukocytes, followed
by thymus and spleen. Very weak expression was
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detected in the small intestine and colon. This distri-
bution contrasts clearly with that of DOCK180,
which was expressed in all tissues except peripheral
blood leukocytes. For the detection of DOCK2 pro-
tein, we raised antisera by immunizing rabbits with
the bacterially expressed DOCK2 carboxyl-terminal
region. Among various cell lines tested, expression of
DOCK2 protein was limited to those derived from T
cells, B cells, and monocytes. Representative data are
shown in Fig. 2b. DOCK2 was detected in Jurkat T
cells, Ramos B cells, and THP-1 monocytes, but not
in 293T kidney cells. Again, we found that expres-
sion of DOCK180 was complementary to that of
DOCK2. These results were also con¢rmed by
Northern blotting analysis (data not shown).
Fig. 2. Distribution of DOCK2 in tissues and cell lines. (a) Ny-
lon ¢lters blotted with human mRNAs of various tissues were
hybridized with [32P]-dCTP-labeled cDNA probes of DOCK2
and DOCK180. (b) 293T, Jurkat, Ramos, and THP-1 cells are
derived from human kidney cells, T cells, B cells, and mono-
cytes, respectively. Total cell lysates were separated by SDS-
polyacrylamide gel electrophoresis and analyzed by immuno-
blotting with antisera against DOCK180 or DOCK2, as indi-
cated on the right.
Fig. 3. Immunohistochemical analysis of DOCK2. Formalin-
¢xed, para⁄n-embedded tissues from human cadavers were
used for analysis. Specimens were incubated with anti-DOCK2
serum, followed by detection by a peroxidase-conjugated strep-
tavidin-DAB readout system. The nuclei of the cells were coun-
ter-stained with Giemsa. Arrows and arrowheads indicate lym-
phocytes and macrophages, respectively.
Fig. 1. Alignment of the amino acid sequences of the CDM-family proteins. (a) The nucleotide sequences reported for each protein
are demonstrated as solid lines below the schematic representation of the structure of the CDM-family proteins. Alignment (b) and
dendrogram (c) of the CDM-family proteins were drawn by the use of Clustal W. Amino acid sequences overlapping in all seven
CDM-family proteins were used for the analysis. Asterisks indicate amino acids conserved absolutely. Double stars demonstrate the
conserved amino acid substitutions. The single stars are semi-conserved amino acid substitutions.
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3.3. Immunohistochemical study of DOCK2
Because the mRNA used for the Northern analysis
was extracted from organs, the faint bands detected
in the small intestine and colon may not necessarily
re£ect the expression of DOCK2 in the parenchymal
cells of these organs. Thus, we examined the expres-
sion of DOCK2 immunohistochemically (Fig. 3). In
the heart, liver, and lung, myocytes, hepatocytes, and
lung epithelial cells did not express DOCK2; how-
ever, macrophages in the interstitium or alveolus
were detected by the anti-DOCK2 antibody. Lym-
phocytes in the lymph nodes showed strong reactiv-
ity with anti-DOCK2. Most of the hematopoietic
cells also expressed DOCK2, although the level of
expression varied from a cell to cell. In the tonsil,
again, cells positive for DOCK2 were limited to mac-
rophages and lymphocytes.
3.4. Inability to bind to CrkII
We recently reported that DOCK180 is involved in
signaling from focal contacts by means of the CrkII-
p130Cas complex [20]. Because both the CrkII and
p130Cas proteins are expressed rather ubiquitously
[2,15,21], DOCK2 may function similarly to
DOCK180 in non-adherent cells. Therefore, we ex-
amined whether DOCK2 binds to CrkII (Fig. 4).
293T cells expressing CrkII with either DOCK180
or DOCK2 were lysed and immunoprecipitated
with anti-CRK rabbit serum. DOCK180 co-precipi-
Fig. 5. Binding of DOCK2 to Rac1 and Rac2. (a) 293T cells
transfected with the expression vectors were lysed, and GST-
tagged Rac proteins were collected on glutathione Sepharose.
Total cell lysates (left panel) and proteins bound to the beads
(right panel) were analyzed by immunoblotting with anti-Flag
monoclonal antibody (upper panels) or anti-GST polyclonal
antibody (lower panel). Transfected plasmids are: lanes 1,
pCXN2-Flag-DOCK1 and pEBG-Rac1; lanes 2, pCXN2-Flag-
DOCK2 and pEBG-Rac1; lanes 3, pCXN-Flag-DOCK2 and
pEBG-Rac2; lanes 4, pCXN-Flag-DOCK2 and pEBG. (b)
Schematic representation of DOCK2 mutants; wild-type,
pCXN-Flag-DOCK2; vN, pCXN-Flag-DOCK2-vN; vCL,
pCXN-Flag-DOCK2-vCL; vCS, pCXN-Flag-DOCK2-vCS. (c)
293T cells were transfected with pEBG-Rac1 and the vectors
denoted at the top and analyzed as in (a).
Fig. 4. Binding of DOCK180, but not DOCK2, to CrkII. 293T
cells were co-transfected with pCXN2-CrkII (indicated as
CrkII) and pCXN2-Flag-DOCK2 (DOCK2) or pCXN2-Flag-
DOCK180 (DOCK180). Cells were lysed and immunoprecipi-
tated with anti-Crk rabbit serum. Total cell lysates and immu-
noprecipitates were separated by SDS-PAGE and analyzed by
immunoblotting with anti-Flag monoclonal antibody (top) or
anti-Crk monoclonal antibody (bottom).
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tated with CRKII as reported previously; however,
DOCK2 did not. Thus, DOCK2 cannot bind to
CrkII even when both proteins are expressed in ex-
cess. In accordance with this ¢nding, we could not
observe co-immunoprecipitation of Crk and DOCK2
in Jurkat cells (data not shown).
3.5. Binding of DOCK2 to Rac1 and Rac2
Recently, we have shown that DOCK180 binds to
and activates Rac1 [8]. Thus, we tested whether
DOCK2 also binds to Rac1 and Rac2 in 293T cells.
293T cells were transfected with expression vectors
for GST, GST-Rac1 or GST-Rac2 and Flag-
DOCK1 and Flag-DOCK2. GST and GST-tagged
proteins were precipitated with glutathione beads
from cell lysate and proteins bound to the beads
were analyzed by immunoblotting using anti-Flag
antibody. As shown in Fig. 5a, DOCK2 bound to
both GST-Rac1 and GST-Rac2, but not to GST.
For the determination of the region necessary for
the binding to Rac, we used deletion mutants of
DOCK2 shown in Fig. 5b. Since both vN and
vCL mutants bound to GST-Rac1, the Rac1-binding
domain was assigned to amino acids 939 to 1323.
However, it should be pointed out that the vCL
mutant (amino acids 1^1323) bound to Rac1 signi¢-
cantly less than did wild-type DOCK2, suggesting
that more of the carboxyl-terminal region appears
to be required for optimal binding.
3.6. Activation of Rac1 by DOCK2
We examined whether DOCK2 promotes the gua-
nine nucleotide exchange reaction of Rac1 by ex-
pressing GST-Rac1 with DOCK2 (Fig. 6a and b).
DOCK2 increased the GTP/GDP ratio on Rac1, as
did DOCK180. Vav, which is known as a guanine
nucleotide exchange protein for Rac1 [22], increased
the GTP/GDP ratio only slightly in our assay sys-
tem. The levels of protein expression among
DOCK180, DOCK2, and Vav were comparable
(Fig. 6c). Thus, at least in 293T cells, DOCK2 facil-
itates the guanine nucleotide exchange reaction more
e⁄ciently than does Vav. Vav may require an addi-
tional signal, such as tyrosine phosphorylation [22],
for its optimal enzymatic activity.
4. Discussion
The CDM-family proteins are evolutionarily con-
served from nematodes to man (Fig. 1). Moreover,
the presence of at least four human proteins belong-
ing to this family demonstrates that the CDM-family
proteins have also diverged into several human pro-
teins during evolution. We have focused on the sim-
ilarities and the di¡erences between DOCK180 and
DOCK2, which are most closely related to each oth-
er among the four human CDM-family proteins.
The expression of DOCK180 and DOCK2 is
strictly exclusive from one the other, as far as we
have examined. DOCK2 is expressed only in non-
adherent cells such as T cells, B cells, and macro-
phages in the peripheral blood and tissues, whereas
DOCK180 is expressed only in adherent cells. To
examine whether this di¡erential expression depends
on the state of the cells, we treated THP-1 monocyte-
derived cells with phorbol ester, which induces di¡er-
entiation of THP-1 cells into macrophage-like adher-
ent cells [23]. We observed that phorbol ester cannot
induce DOCK180 nor down-regulate DOCK2 in
THP-1 cells after di¡erentiation (data not shown).
Thus, the expression of DOCK2 appears to be re-
lated to the cell lineage rather than to the adhesion
signals.
Fig. 6. Activation of Rac1 by DOCK2. (a) 293T cells were
transfected with pGEX-Rac1 and expression vectors for the
proteins indicated at the bottom. Cells were labeled with 32Pi,
and the guanine nucleotides bound to Rac were separated by
TLC as described in the text. (b) The ratio of GTP versus total
guanine nucleotides were calculated from two independent ex-
periments. Errors are shown as bars. (c) In a parallel experi-
ment, cell lysates were analyzed by immunoblotting with anti-
Flag antibody. Bars at the left indicate the positions of molecu-
lar size markers; 116, 99, and 66 kDa from the top.
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We have positioned DOCK180 downstream of the
p130Cas-CrkII complex, which is activated by inte-
grin stimulation [20]. Because both p130Cas and
CrkII are expressed ubiquitously [2,15], we specu-
lated that DOCK2 may substitute for the role of
DOCK180 in these cells. However, we never detected
binding of CrkII to DOCK2; thus, there was no
involvement of DOCK2 in CrkII signaling. Neither
of the other putative human DOCK180-like proteins,
KIAA0299 and GS034D21, contains the Crk-binding
sequence at its carboxyl-terminus; therefore, each of
the DOCK180-like proteins may be positioned in
di¡erent signaling cascades.
DOCK2 binds to and activates Rac1 in a manner
similar to DOCK180 [8]. However, the e¡ects of
these two proteins on the morphology of the cells
are astonishingly di¡erent. DOCK180 per se does
not induce a morphologic change in adherent cells;
however, with the membrane localization signals or
with the co-expression of p130Cas and CrkII,
DOCK180 induces spreading of the cells [7,20]. In
contrast, the expression of DOCK2 induced round-
ing and detachment of NRK cells from the dishes
(data not shown). A similar phenomenon was ob-
served when we used NIH 3T3 cells (data not
shown). Thus, apparently the activation of Rac1 by
DOCK180 or by DOCK2 does not result in the same
outcome for the cell morphology. The di¡erence in
the intracellular localization of DOCK180 and
DOCK2 might account for this discrepancy.
Rac proteins play pivotal roles in the reorganiza-
tion of the cell architecture and also in gene regula-
tion in most cells [24]. However, Rac is also impli-
cated in a function speci¢c to macrophages and
granulocytes. In these cells, Rac1 is involved in
NADPH oxidation by means of binding to p67-
phox [25^27]. Mutations in p67-phox that abrogate
the binding to Rac cause chronic granulomatous dis-
ease [28]. The coincidence of the expression of
DOCK2 in phagocytic cells may suggest the involve-
ment of DOCK2 in phagocytosis. It is noteworthy
that DOCK180 can complement only one of the two
defects in ced-5 mutant nematodes [10]; DOCK180
expression restores the distal tip cell migration of the
ced-5 mutant, but not the engulfment of the apop-
totic body. This observation suggests the involve-
ment of other DOCK180-like proteins, possibly
DOCK2, in phagocytosis in man. It is not yet known
whether DOCK2 plays any role in phagocytosis and
NADPH oxidation.
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